112 related articles for article (PubMed ID: 3755413)
1. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
Humar F; Maras P; Musitelli G; Camerini F
G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
[TBL] [Abstract][Full Text] [Related]
2. [Hemodynamic effects of sublingual molsidomine in patients with or without cardiac failure].
Rigaud M; Luwaert R; Jouret G; Bardet J; Bourdarias JP
Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):523-8. PubMed ID: 6421222
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.
Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J
Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742
[TBL] [Abstract][Full Text] [Related]
4. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
[TBL] [Abstract][Full Text] [Related]
5. [Effect of nitroglycerin and N-ethoxycarbonyl-3-morpholinosydnonomine on the walls of large arteries].
Babalis D; Levy B; Azancot I; Georgiopoulos G; Beaufils P; Slama R
Arch Mal Coeur Vaiss; 1982 Jun; 75(6):677-86. PubMed ID: 6810797
[TBL] [Abstract][Full Text] [Related]
6. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
[TBL] [Abstract][Full Text] [Related]
7. [Effect of the acute administration of molsidomine in refractory congestive heart failure. A double-blind randomized non-invasive study].
Coletta C; Galati A; Carunchio A; Salustri A; Bordi L; Fera MS
G Ital Cardiol; 1986 Mar; 16(3):232-6. PubMed ID: 3755412
[TBL] [Abstract][Full Text] [Related]
8. [Substituted sydnonimines: hemodynamic effects and distribution of coronary blood flow in normal and ischemic myocardium].
Mosca SM; Gelpi RJ; Cingolani HE
Acta Physiol Pharmacol Latinoam; 1985; 35(3):361-73. PubMed ID: 2938418
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic changes produced by molsidomine in patients with congestive myocardiopathy.
Otero F; Fernández Berges DJ; Milei J; Agejas R; Vázquez A; Pautasso E
Acta Cardiol; 1984; 39(5):353-63. PubMed ID: 6334953
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of molsidomine in patients with heart failure following acute myocardial infarction.
Cantelli I; Lolli C; Brunelli A; Bracchetti D
Am Heart J; 1985 Mar; 109(3 Pt 2):716-9. PubMed ID: 3838410
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effects of molsidomine by cardiac equilibrium blood pool scintigraphy.
Chevigné M; Rigo P; Kassab A; Kulbertus H
Am Heart J; 1985 Mar; 109(3 Pt 2):658-61. PubMed ID: 3838403
[TBL] [Abstract][Full Text] [Related]
12. Analysis of oral molsidomine effects on ventricular function and dimensions in the conscious dog.
Fiedler VB; Göbel H; Nitz RE
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):56-75. PubMed ID: 6409016
[TBL] [Abstract][Full Text] [Related]
13. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
Larbig DT; Milstrey HR; Nasse H; Kahle T
Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
[TBL] [Abstract][Full Text] [Related]
14. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
Witchitz S; Kolsky H; Moisson P; Valette H
Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
16. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
18. Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure.
Franciosa JA; Leddy CL; Schwartz DE
Z Kardiol; 1983; 72 Suppl 3():168-72. PubMed ID: 6666217
[TBL] [Abstract][Full Text] [Related]
19. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Miller RR; Awan NA; Maxwell KS; Mason DT
N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
[TBL] [Abstract][Full Text] [Related]
20. [Hypotension induced by molsidomine or trinitroglycerin].
Dassier P; Blanloeil Y; Pinaud M; Bodin D; Vandeville B
Cah Anesthesiol; 1985; 33(4):309-13. PubMed ID: 3931864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
